Testing the effect of SST2 and 5 activation on proliferation of thyroid medullary carcinoma cells, it was observed that SST2-selective analogs induce dose-related inhibition of proliferation, whereas SST5-selective analogs cause an increase (Zatelli et al., 2001). This evidence concerns the gene SSTR2 and medullary thyroid gland carcinoma.